ChemicalBook
Chinese English Germany Korean

Shanghai Star Pharmaceutical Chemical Technology Co., Ltd. 企業の連絡先情報

名前:Shanghai Star Pharmaceutical Chemical Technology Co., Ltd.
電話番号:021-58521787
電子メール:starpharmsh@gmail.com
国籍:China
ウェブサイト:www.starpharm-sh.com
商品の合計数:208
1 2 3

製品カタログ

Argirelineアセチルヘキサペプチド-3616204-22-9C34H60N14O12S
Rosuvastatin methyl esterメチル=(3R,5S,E)-7-[4-(4-フルオロフェニル)-6-イソプロピル-2-(N-メチルメタンスルホンアミド)ピリミジン-5-イル]-3,5-ジヒドロキシヘプタ-6-エノアート147118-40-9C23H30FN3O6S
4-Chloromethyl-5- meth-yl-1,3-dioxol- 2-one4-クロロメチル-5-メチル-1,3-ジオキソール-2-オン80841-78-7C5H5ClO3
Ethyl 4-(1-hydroxy-1-methyl-ethyl)-2-propyl- imidazole-5- carboxylate4-(2-ヒドロキシ-2-プロピル)-2-プロピル-1H-イミダゾール-5-カルボン酸エチル144689-93-0C12H20N2O3
Methyl 4'-bromomethyl biphenyl-2-carboxylate2-[4-(ブロモメチル)フェニル]安息香酸メチル114772-38-2C15H13BrO2
2-n-Propyl-4-methyl-6-(1-methylbenzimi- dazole-2-yl)benz- imidazoleビス-ベンゾイミダゾル152628-02-9C19H20N4
Valsartan methyl ester137863-17-3C25H31N5O3
Silodocin P-1 oxalate
Rabamipide Na
Dapoxetine free baseダポキセチン119356-77-3C21H23NO
Tadanafil P-1クロロプレタダラフィル171489-59-1C22H19ClN2O5
Dantrolene free baseダントロレン85008-71-5C14H10N4O5
Varenicline free baseバレニクリン249296-44-4C13H13N3
N-(4-cyanophenyl)- glycineN-(4-シアノフェニル)グリシン42288-26-6C9H8N2O2
Ethyl N-[3-amino-4-(methylamino)benzoyl]-N- pyridin-2-yl-beta- alaninate3-[3-アミノ-4-(メチルアミノ)-N-(2-ピリジル)ベンズアミド]プロピオン酸エチル212322-56-0C18H22N4O3
Ethyl N-[(2-{[(4-cyanophenyl)amino]methyl}-1- methyl-1H-benz- imidazol-5-yl)- carbonyl]-N-pyridin- 2-yl-beta-alaninate211915-84-3C27H26N6O3
(S)-2,3-Dimethyl-3-(( triethylsilyl)oxy)butan-1-ol957997-83-0C12H28O2Si
(S)-3-(methoxymetho-xy)-2,3-dimethylbutan-1-ol1217719-34-0C8H18O3
(R)-(2,3-dimethyl-3-(( triethylsilyl) oxy)butyl)- diphenylphosphine oxide1227926-70-6C24H37O2PSi
(R)-(2,3-dimethyl-3- butyl)diphenyl phosphineoxideC18H23OP
(2S)-2-((1R,3aR,7aR)-4-((tert-butyldimethylsilyl)oxy)-7a-methyloctahydro-1H-inden-1-yl)propan-1-ol215509-33-4C19H38O2Si
(1R,3aR,7aR)-1-((2R,5S,E)-6-(methoxy methoxy)-5,6-dimethylhept-3-en-2-yl)-7a- methylhexahydro- 1H-inden-4(2H)-one100858-26-2C21H36O3
(1R,3aR,7aR)-1-((2R,5S,E)-5,6-dimethyl-6- ((triethylsilyl)oxy)hept-3-en-2-yl)-7a-methyl hexahydro-1H- inden-4(2H)-one950586-26-2C25H46O2Si
2-((3R,5R)-3,5-bis(( tert-butyldimethyl silyl)-oxy) cyclohexylidene) ethanol139356-37-9C20H42O3Si2
(2-((3R,5R)-3,5-bis(( tert-butyldimethyl- silyl)oxy)cyclohexyl- idene)ethyl)diphenylphosphine oxide139356-39-1C32H51O3PSi2
ATB-12-フルオロ-1-イソプロピル-4-メトキシベンゼン1262414-96-9C10H13FO
ATB-42-クロロ-5-(トリフルオロメチル)ベンジルブロミド237761-77-2C8H5BrClF3
Diallyl bisphenol A4,4'-(ジメチルメチレン)ビス[2-(2-プロペニル)フェノール]1745-89-7C21H24O2
5,6-Dihydroxyindole1H-インドール-5,6-ジオール3131-52-0C8H7NO2
5,6-Dihydroxy-1H-Indole-2-Carboxylic Acid5,6-ジヒドロキシ-1H-インドール-2-カルボン酸4790-08-3C9H7NO4
Methyl 5,6-dihydroxy-1H-indole-2-Carboxylate10131-14-3C10H9NO4
2,2-dimethyl-5H-1,3-dioxol[4,5-f]indole437757-21-6C11H11NO2
(E)-methyl 3-(2,2-dimethylbenzo[d][1,3]dioxol-5-yl)acrylate2187481-85-0C13H14O4
Cis-Sertraline-D-Madenlic acid
Sitagliptin impurity 1~5(S)-3-アミノ-4-(2,4,5-トリフルオロフェニル)ブタン酸塩酸塩1217809-78-3C10H11ClF3NO2
Methyl caffeateカフェイン酸メチル67667-67-8C10H10O4
Quinic acidD-(-)-キナ酸77-95-2C7H12O6
Phenethyl caffeateカフェイン酸フェネチル104594-70-9C17H16O4
ATB-9875444-10-3C12H9F6NO2
Caffeic acidカフェイン酸331-39-5C9H8O4
Landiolol impurity 11253907-85-5C25H40ClN3O8
Landiolol impurity 21253907-81-1C25H40ClN3O8
Landiolol impurity 31253907-83-3C25H40ClN3O8
Dabigatran amidine HCl211914-50-5
Indobufen impurity 236691-02-8C20H21NO3
Indobufen impurity 3203313-55-7C18H19NO4
Sarpogrelate HClサルポグレラート125926-17-2C24H31NO6
BP9841-(ジメチルアミノ)-3-[2-[2-(3-メトキシフェニル)エチル]フェノキシ]-2-プロパノル酸135261-74-4C20H28ClNO3
Crisaborole impurity 1906673-43-6C14H11BO5
Crisaborole impurity 21187188-59-5C14H12BNO4
Crisaborole impurity 3888967-63-3C14H11NO2
Sitagliptin impurity 11345822-87-8C16H19F5N5O5P
Sitagliptin impurity 21345822-86-7C16H19F5N5O5P
Sitagliptin impurity 3りん酸ENT-シタグリプチン823817-58-9C16H16F6N5O5P
Sitagliptin impurity 4823817-57-8C16H18F6N5O5P
Sitagliptin impurity 5837430-15-6C6H5F3N4O
Lesinurad sodiumレシヌラドナトリウム1151516-14-1C17H13BrN3O2S.Na
de-bromo Lesinurad1533519-93-5C17H15N3O2S
Benserazide HClベンセラジド·塩酸塩14919-77-8C10H16ClN3O5
Benserazide P-11353749-74-2C10H14ClN3O5
Silodosin P-1 oxalate1883697-83-3C27H32F3N3O7
Silodosin impurity 2175870-21-0C25H30F3N3O4
Rebamipide sodium salt
Rebamipide meta-Cl impurity90098-05-8C19H15ClN2O4
Roxatidine impurity 11-(3-ヒドロキシベンジル)ピペリジン73279-04-6C12H17NO
Roxatidine impurity 378274-00-7C16H24N2O2
Roxatidine impurity 497900-87-3C17H27ClN2O2
Elagolix impurity 12248628-93-3C32H28F5N3O4
Elagolix impurity 32375499-61-7C32H31F4N3O5
Erdosteineエルドステイン84611-23-4C8H11NO4S2
IlaprazoleIY-81149172152-36-2C19H18N4O2S
Ilaprazole intermediate P-3172152-53-3C11H9N3S
Ilaprazole impurity 1172152-37-3C19H18N4O3S
Ilaprazole impurity 384445-90-9C9H9N3OS
Ilaprazole impurity 41018229-53-2C11H9N3O
Fexuprazan P-41902955-29-6C13H11F2NO3
Fexuprazan P-11902955-31-0C18H12F3NO4S
N-Bn Tegoprazan parent nucleus1640981-20-9C18H19N3O2
N-Ts Tegoprazan P-14942485-42-9
N-Bn Tegoprazan P-1
R-Tegoprazan isomer942195-56-4C20H19F2N3O3
Vonoprazan Fumarate1260141-27-2C21H20FN3O6S
Deoxycholic acid P-1181270-68-8C28H46O5
Deoxycholic acid impurity 1
Deoxycholic acid impurity 2デオキシコール酸エチル69519-35-3C26H44O4
Deoxycholic acid impurity 3
Sodium Picosulfate impurity ASODIUM PICOSULFATE RELATED COMPOUND A (4-[(PYRIDIN-2-YL)(4-HYDROXYPHENYL)METHYL]PHENYL SODIUM SULFATE)32500-19-9C18H16NNaO5S
Diclofenac Epolamine impurity 2ジクロフェナックカルボン酸 (DICLOFENAC METABOLITE)13625-57-5C13H9Cl2NO2
Diclofenac Epolamine impurity 42-[(2-ブロモ-6-クロロフェニル)アミノ]ベンゼン酢酸127792-23-8C14H11BrClNO2
Diclofenac Epolamine impurity 642088-52-8C8H8N2
Diclofenac Epolamine impurity 7172494-87-0C13H11Cl2N
Pranoprofen P-2146330-68-9C15H12ClNO2
Pranoprofen impurity B52549-22-1C15H11NO3
Raloxifene HCl P-184541-36-6C30H32ClNO4S
Raloxifene impurity 184541-37-7C29H29NO4S.ClH
Raloxifene impurity 2173773-26-7C29H29NO4S.ClH
Glimepiride Cis isomerCIS-グリメピリド684286-46-2C24H34N4O5S
Glimepiride methyl esterグリメピリド関連化合物C (GLIMEPIRIDE URETHAグリメピリドウレタン-(3-ETHYL-4-METHYL-2-OXO-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDO)ETHYL)PHENYL)SULFONYL)CARBAMATE)119018-30-3C18H23N3O6S
Oseltamivir degradation impurity 1
Oseltamivir degradation impurity 2
1,1'-(4-(ethylamino)-6-hydroxy-1,3-phenylene)bis(ethan-1-one)79324-49-5C12H15NO3
Iodonitrotetrazolium chloride2-(4-ヨードフェニル)-3-(4-ニトロフェニル)-5-フェニルテトラゾリウム クロリド146-68-9C19H13ClIN5O2
1,1'-(4-amino-6-hydroxy-1,3-phenylene)bis(ethan-1-one)79324-45-1C10H11NO3
1,1'-(4-(allyloxy)-6-(ethylamino)-1,3-phenylene)bis(ethan-1-one)79324-50-8C15H19NO3
4-chloro-5-nitro-2-(propylthio)pyrimidine2518331-26-3C7H8ClN3O2S
4-methoxy-5-nitro-2-(propylthio)pyrimidine2514951-26-7C8H11N3O3S
1-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione69998-14-7C7H10N2O3
Mavacamten MYK461 (S)-3-isopropyl-6-((1-phenylethyl)amino)pyrimidine-2,4(1H,3H)-dione1642288-47-8C15H19N3O2
N-(2,4-diacetyl-5-hydroxyphenyl)acetamide79324-44-0C12H13NO4
5-amino-2-(propylthio)pyrimidin-4-ol
1,1'-(4-(ethylamino)-6-hydroxy-5-propyl-1,3-phenylene)bis(ethan-1-one)79324-51-9C15H21NO3
6-chloro-3-isopropylpyrimidine-2,4(1H,3H)-dione887581-47-7C7H9ClN2O2
LCL161(S)-N-[(S)-1-シクロヘキシル-2-[(2S)-2-[4-(4-フルオロベンゾイル)-2-チアゾリル]-1-ピロリジニル]-2-オキソエチル]-2-(メチルアミノ)プロパンアミド1005342-46-0C26H33FN4O3S
GDC-02764-(アダマンタン-1-イルメトキシ)-N-(アゼチジン-1-スルホニル)-5-シクロプロピル-2-フルオロベンズアミド1494581-70-2C24H31FN2O4S
GSK-2110183C impurity d-M14
GSK-2110183Cアフレセルチブ1047644-62-1C18H17Cl2FN4OS
Mefatinib1417695-74-9C21H19ClF3N5O2
GDC-0310 intermediate 11788072-29-6C22H31ClFNO5
GDC-0310 intermediate 3
MK-1755 intermediate 42-アリル-1-(6-(2-ヒドロキシプロパン-2-イル)ピリジン-2-イル)-6-(メチルチオ)-1H-ピラゾロ[3,4-D]ピリミジン-3(2H)-オン955369-56-9C17H19N5O2S
GDC-03101788063-52-4C25H29Cl2FN2O4S
GDC-0310 intermediate 21788072-30-9C25H36FNO5
d-Mefatinib
Carbamic acid, N-?[(1S)?-?1-?cyclohexyl-?2-?[(2S)?-?2-?[4-?(4-?fluorobenzoyl)?-?2-?thiazolyl]?-?1-?pyrrolidinyl]?-?2-?oxoethyl]?-?, 1,?1-?dimethylethyl ester1005342-80-2C27H34FN3O4S
MK-1755 intermediate 22007908-48-5C16H24N4O4S
MK-1755 intermediate 32-アリル-6-(メチルチオ)-1H-ピラゾロ-[3,4-D]ピリミジン-3(2H)-オン955368-90-8C9H10N4OS
GDC-0310 intermediate 42448100-15-8C25H28Cl2FNO3
JH-VIII-157-022-(4-{3-シアノ-9-エチル-6,6-ジメチル-11-オキソ-5H,6H,11H-ベンゾ[b]カルバゾール-8-イル}-1H-ピラゾール-1-イル)-N,N-ジメチルアセトアミド1639422-97-1C28H27N5O2
GSK-2110183C impurity M14
(S)-(4-Fluorophenyl)(2-(pyrrolidin-2-yl)thiazol-4-yl)methanone hydrochloride1263876-35-2C14H14ClFN2OS
Testosterone Tridecanoate488836-58-4C32H52O3
GSK-2110183C intermediate1047630-61-4C9H6Cl2N2O2S
MK-1755アダボセルチブ955365-80-7C27H32N8O2
MK-1755 intermediate 12-アリルカルバジン酸tert-ブチル21075-86-5C8H16N2O2
L-Threonine, N-[4-[2-[4-(4-morpholinylmethyl)phenyl]ethynyl]benzoyl]-, methyl ester728878-12-4C25H28N2O5
Oxobutanedioic acidオキサロ酢酸328-42-7C4H4O5
L-Threonine, N-(4-ethynylbenzoyl)-, methyl ester728878-24-8C14H15NO4
4-aMino-3-Methoxy-N-(1-Methylpiperidin-4-yl)benzaMide876126-60-2C14H21N3O2
CHIR090(2S,3R)-2-[[4-[[4-(モルホリノメチル)フェニル]エチニル]ベンゾイル]アミノ]-3-ヒドロキシブタンヒドロキシム酸728865-23-4C24H27N3O5
BI-2536 parent nucleus(7R)-2-クロロ-8-シクロペンチル-7-エチル-7,8-ジヒドロ-5-メチル-6(5H)-プテリジノン755039-55-5C14H19ClN4O
1 2 3
Copyright 2017 © ChemicalBook. All rights reserved